Trabeculectomy with intraoperative 5-fluorouracil. Ophthalmic Surg Lasers 1998 Jul;29(7):552-61
Date
07/23/1998Pubmed ID
9674005Scopus ID
2-s2.0-0031849545 (requires institutional sign-in at Scopus site) 13 CitationsAbstract
BACKGROUND AND OBJECTIVE: To investigate the outcome and complication rates of trabeculectomy following the combined use of intraoperative, topical 5-fluorouracil (5-FU) and low-dose, postoperative subconjunctival 5-FU injections.
PATIENTS AND METHODS: Forty-one eyes of 41 patients with advanced, medically uncontrolled glaucoma underwent trabeculectomy with intraoperative episcleral application of 5-FU (50 mg/ml for 5 minutes). A variable number of subconjunctival 5-FU injections were administered postoperatively at the discretion of the operating surgeon.
RESULTS: Six-, 12-, and 15-month life-table success rates (5 mm Hg < or = intraocular pressure [IOP < or = 21 mm Hg) were 100%, 97%, and 83%, respectively. Mean postoperative IOP was 12.1 +/- 4.3 mm Hg. An average of 2.2 +/- 1.6 (range 0 to 7) supplemental subconjunctival 5-FU injections were administered postoperatively. Corneal epithelial erosions developed in 7 (17%) of the eyes. Five of 7 patients who underwent subsequent surgical procedures maintained successful control of IOP at an average of 11.0 +/- 4.8 (range 5 to 16) months after the secondary surgery.
CONCLUSION: Trabeculectomy with intraoperative 5-FU is effective in controlling IOP while possibly minimizing the need for frequent postoperative injections and the occurrence of corneal epitheliopathy.
Author List
Sidoti PA, Choi JC, Morinelli EN, Lee PP, Baerveldt G, Minckler DS, Heuer DKAuthor
Dale Heuer MD Emeritus Professor in the Ophthalmology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAged
Aged, 80 and over
Antimetabolites, Antineoplastic
Fluorouracil
Glaucoma
Humans
Intraocular Pressure
Intraoperative Period
Middle Aged
Retrospective Studies
Sclera
Trabeculectomy
Treatment Outcome
Visual Acuity









